208 related articles for article (PubMed ID: 30573632)
1. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
Opstal-van Winden AWJ; de Haan HG; Hauptmann M; Schmidt MK; Broeks A; Russell NS; Janus CPM; Krol ADG; van der Baan FH; De Bruin ML; van Eggermond AM; Dennis J; Anton-Culver H; Haiman CA; Sawyer EJ; Cox A; Devilee P; Hooning MJ; Peto J; Couch FJ; Pharoah P; Orr N; Easton DF; Aleman BMP; Strong LC; Bhatia S; Cooke R; Robison LL; Swerdlow AJ; van Leeuwen FE
Blood; 2019 Mar; 133(10):1130-1139. PubMed ID: 30573632
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
[TBL] [Abstract][Full Text] [Related]
3. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.
Morton LM; Sampson JN; Armstrong GT; Chen TH; Hudson MM; Karlins E; Dagnall CL; Li SA; Wilson CL; Srivastava DK; Liu W; Kang G; Oeffinger KC; Henderson TO; Moskowitz CS; Gibson TM; Merino DM; Wong JR; Hammond S; Neglia JP; Turcotte LM; Miller J; Bowen L; Wheeler WA; Leisenring WM; Whitton JA; Burdette L; Chung C; Hicks BD; Jones K; Machiela MJ; Vogt A; Wang Z; Yeager M; Neale G; Lear M; Strong LC; Yasui Y; Stovall M; Weathers RE; Smith SA; Howell R; Davies SM; Radloff GA; Onel K; Berrington de González A; Inskip PD; Rajaraman P; Fraumeni JF; Bhatia S; Chanock SJ; Tucker MA; Robison LL
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059430
[TBL] [Abstract][Full Text] [Related]
5. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.
Hill DA; Gilbert E; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer M; Storm H; Pukkala E; Stovall M; Curtis RE; Allan JM; Boice JD; Travis LB
Blood; 2005 Nov; 106(10):3358-65. PubMed ID: 16051739
[TBL] [Abstract][Full Text] [Related]
7. Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
Horst KC; Fero KE; Hancock SL; Advani RH; Ikeda DM; Daniel B; Rosenberg SA; Donaldson SS; Hoppe RT
Am J Clin Oncol; 2016 Apr; 39(2):114-9. PubMed ID: 24390271
[TBL] [Abstract][Full Text] [Related]
8. FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma.
Ma YP; van Leeuwen FE; Cooke R; Broeks A; Enciso-Mora V; Olver B; Lloyd A; Broderick P; Russell NS; Janus C; Ashworth A; Houlston RS; Swerdlow AJ
Blood; 2012 Jan; 119(4):1029-31. PubMed ID: 22144180
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
[TBL] [Abstract][Full Text] [Related]
10. Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma.
Horst KC; Hancock SL; Ognibene G; Chen C; Advani RH; Rosenberg SA; Donaldson SS; Hoppe RT
Ann Oncol; 2014 Apr; 25(4):848-851. PubMed ID: 24608191
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
12. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.
Dores GM; Anderson WF; Beane Freeman LE; Fraumeni JF; Curtis RE
Br J Cancer; 2010 Sep; 103(7):1081-4. PubMed ID: 20842115
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors.
Roberti S; van Leeuwen FE; Ronckers CM; Krul IM; de Vathaire F; Veres C; Diallo I; Janus CPM; Aleman BMP; Russell NS; Hauptmann M
J Natl Cancer Inst; 2022 Sep; 114(9):1270-1278. PubMed ID: 35771630
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
Neppelenbroek SIM; Geurts YM; Aleman BMP; Lugtenburg PJ; Rademakers SE; de Weijer RJ; Schippers MGA; Ta BDP; Plattel WJ; Zijlstra JM; van der Maazen RWM; Nijziel MR; Ong F; Schimmel EC; Posthuma EFM; Kersten MJ; Böhmer LH; Muller K; Koene HR; Te Boome LCJ; Bilgin YM; de Jongh E; Janus CPM; van Leeuwen FE; Schaapveld M
J Clin Oncol; 2024 Jun; 42(16):1903-1913. PubMed ID: 38359378
[TBL] [Abstract][Full Text] [Related]
17. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
[TBL] [Abstract][Full Text] [Related]
18. A polygenic risk score for breast cancer risk in a Taiwanese population.
Hsieh YC; Tu SH; Su CT; Cho EC; Wu CH; Hsieh MC; Lin SY; Liu YR; Hung CS; Chiou HY
Breast Cancer Res Treat; 2017 May; 163(1):131-138. PubMed ID: 28205043
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis.
Alm El-Din MA; Hughes KS; Raad RA; Goldberg SI; Aisenberg AC; Niemierko A; Taghian AG
Radiat Oncol; 2009 Jun; 4():19. PubMed ID: 19566943
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.
Gaffney DK; Hemmersmeier J; Holden J; Marshall J; Smith LM; Avizonis V; Tran T; Neuhausen SL
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):539-46. PubMed ID: 11173152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]